Mutations in voltage-gated sodium channels expressed highly in the brain (SCN1A, SCN2A, SCN3A, and SCN8A) are responsible for an increasing number of epilepsy syndromes. In particular, mutations in the SCN3A gene, encoding the pore-forming Na v 1.3 α subunit, have been identified in patients with focal epilepsy. Biophysical characterization of epilepsy-associated SCN3A variants suggests that both gain-and loss-of-function SCN3A mutations may lead to increased seizure susceptibility. In this report, we identified a novel SCN3A variant (L247P) by whole exome sequencing of a child with focal epilepsy, developmental delay, and autonomic nervous system dysfunction. Voltage clamp analysis showed no detectable sodium current in a heterologous expression system expressing the SCN3A-L247P variant. Furthermore, cell surface biotinylation demonstrated a reduction in the amount of SCN3A-L247P at the cell surface, suggesting the SCN3A-L247P variant is a trafficking-deficient mutant. To further explore the possible clinical consequences of reduced SCN3A activity, we investigated the effect of a hypomorphic Scn3a allele (Scn3a Hyp ) on seizure susceptibility and behavior using a gene trap mouse line. Heterozygous Scn3a mutant mice (Scn3a +/Hyp ) did not exhibit spontaneous seizures nor were they susceptible to hyperthermia-induced seizures. However, they displayed increased susceptibility to electroconvulsive (6 Hz) and chemiconvulsive (flurothyl and kainic acid) induced seizures. Scn3a +/Hyp mice also exhibited deficits in locomotor activity and motor learning. Taken together, these results provide evidence that loss-of-function of SCN3A caused by reduced protein expression or deficient trafficking to the plasma membrane may contribute to increased seizure susceptibility.
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Introduction
Voltage-gated sodium channels (VGSCs) are responsible for the initiation and propagation of action potentials in excitable cells such as neurons. In the mammalian brain, the most highly expressed VGSC α subunits are SCN1A, SCN2A, SCN3A, and SCN8A, which encode Na v 1.1, Na v 1.2, Na v 1.3, and Na v 1.6 respectively. Mutations in these VGSCs are responsible for an increasing number of epilepsy syndromes (Escayg et al., 2000; Estacion et al., 2014; Fung et al., 2015; Howell et al., 2015; Schwarz et al., 2016; Sugawara et al., 2001; Surovy et al., 2016) .
Mutations in SCN1A have been established as the main cause of Dravet syndrome and have also been identified in some families with generalized epilepsy with febrile seizures plus (GEFS+) (Escayg and Goldin, 2010; Scheffer et al., 2009; Volkers et al., 2011) . SCN2A mutations have been identified in patients with benign familial neonatal-infantile seizures, and both SCN2A and SCN8A mutations have been identified in some cases of severe epileptic encephalopathies (de Kovel et al., 2014; Estacion et al., 2014; Hackenberg et al., 2014; Heron et al., 2002; Sugawara et al., 2001; Vaher et al., 2014; Veeramah et al., 2012) .
To date, only a few SCN3A mutations have been identified in patients with focal epilepsy. Electrophysiological analysis of these mutations in either transfected rat hippocampal pyramidal neurons (Estacion et al., 2010; Holland et al., 2008) or tsA201 cells (Chen et al., 2015; Vanoye et al., 2014) revealed increased persistent sodium current or elevated ramp currents. In contrast, there is one report of an SCN3A mutation, N302S, identified through a genetic screen of GEFS+ patients, that resulted in depolarizing shifts in voltage-dependent activation and inactivation, as well as slower recovery from slow inactivation, thereby predicting a reduction in channel activity (Chen et al., 2015 
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